BOCCELLATO, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 372
EU - Europa 122
AS - Asia 114
SA - Sud America 1
Totale 609
Nazione #
US - Stati Uniti d'America 370
CN - Cina 44
SG - Singapore 41
IT - Italia 39
IE - Irlanda 31
SE - Svezia 19
UA - Ucraina 10
IN - India 7
VN - Vietnam 6
FR - Francia 5
ID - Indonesia 5
BY - Bielorussia 4
KR - Corea 4
PL - Polonia 4
DE - Germania 3
HK - Hong Kong 3
CA - Canada 2
FI - Finlandia 2
RO - Romania 2
AR - Argentina 1
BE - Belgio 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 609
Città #
Chandler 78
Santa Clara 52
Singapore 37
Dublin 31
Fairfield 19
Ashburn 11
Houston 10
Beijing 9
Columbus 9
Nyköping 9
Torino 9
Ann Arbor 7
Hangzhou 7
Medford 7
Princeton 7
Guangzhou 6
New York 6
Seattle 6
Cambridge 5
Chennai 5
Jakarta 5
Wilmington 5
Bologna 4
Canelli 4
Dong Ket 4
Jacksonville 4
San Diego 4
San Mateo 4
Seoul 4
Warsaw 4
Fremont 3
Guiyang 3
Hong Kong 3
Redwood City 3
Turin 3
Upper Marlboro 3
Boston 2
Hebei 2
Helsinki 2
Milan 2
Munich 2
Nanjing 2
Naples 2
Norwalk 2
Rome 2
Woodbridge 2
Aiello Del Sabato 1
Bad Endorf 1
Brussels 1
Buenos Aires 1
Chengdu 1
Chicago 1
Dongguan 1
East Brunswick 1
Fort Collins 1
Izmir 1
Jaipur 1
Leawood 1
Los Angeles 1
Montreal 1
Pune 1
Quinta Do Conde 1
Riverton 1
Silver Spring 1
Toronto 1
Venezia 1
Washington 1
Totale 431
Nome #
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs 106
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 97
Real life use of bendamustine in elderly patients with lymphoid neoplasia 96
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 78
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 71
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 61
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia 59
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia 33
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 27
Totale 628
Categoria #
all - tutte 2.402
article - articoli 0
book - libri 0
conference - conferenze 269
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 1 5
2020/2021108 1 4 3 7 16 4 10 10 13 4 2 34
2021/2022129 9 7 12 6 10 2 10 2 4 12 29 26
2022/2023172 19 18 3 16 14 42 9 11 24 3 6 7
2023/202482 10 15 5 3 2 21 0 3 1 6 8 8
2024/2025131 3 6 11 31 71 9 0 0 0 0 0 0
Totale 628